Background Patients with incomplete surgical resection of medulloblastoma are controversially
regarded as having a marker of high-risk disease, which leads to patients undergoing …

The development of targeted anti-cancer therapies through the study of cancer genomes is
intended to increase survival rates and decrease treatment-related toxicity. We treated a …

In cancer, recurrent somatic single-nucleotide variants—which are rare in most paediatric
cancers—are confined largely to protein-coding genes 1 , 2 – 3 . Here we report highly …

While the preponderance of morbidity and mortality in medulloblastoma patients are due to
metastatic disease, most research focuses on the primary tumor due to a dearth of metastatic …

Medulloblastoma, a common pediatric malignant central nervous system tumour, represent
a small proportion of brain tumours in adults. Previously it has been shown that in adults, …

Medulloblastoma (MB) is one of the most frequent malignant brain tumors in children. The
current standard treatment regimen consists of surgical resection, craniospinal irradiation, and …

Glioblastoma is one of the most common malignant brain tumors. The prognosis for glioblastoma
is still very poor despite intensive treatment by surgery, radiation, and chemotherapy. …

Cancer-specific cell surface antigens are ideal therapeutic targets for monoclonal antibody (mAb)–based
therapy. Here, we report that multiple myeloma (MM), an incurable …

For improvement of prognosis for glioblastoma patients, which remains poor, identification
and targeting of glioblastoma progenitor cells are crucial. In this study, we found that the …

To investigate the safety of combined Wilms tumor 1 peptide vaccination and temozolomide
treatment of glioblastoma, a phase I clinical trial was designed. Seven patients with …